Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Impacto de la Adopción y Entrenamiento de Perros en Veteranos con Síntomas de Estrés Postraumático y/o Otras Condiciones de Salud Mental (VCRM)

6 de noviembre de 2026 actualizado por: Beth Pratt, Florida Atlantic University

Evaluación de Indicadores Biopsicosociales Vinculados a la Respuesta al Tratamiento con Intervención Canina en Veteranos con Síntomas de Estrés Postraumático y/o Otras Condiciones de Salud Mental

The goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main questions it aims to answer are:

  • Does the dog adoption and training program decrease posttraumatic stress symptoms in veterans with self-reported posttraumatic stress symptoms?
  • Does the dog adoption and training program decrease stress and improve psychosocial health in veterans with self-reported posttraumatic stress symptoms?
  • Does the dog adoption and training program decrease inflammation, increase oxytocin, and change the structure and resting-state function of specific brain regions in veterans with self-reported posttraumatic stress symptoms?

Participants will:

  • Attend eight one-hour professional dog training sessions within a 10-week period.
  • Visit the clinical research unit four times during the study for data collection.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

120

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Florida
      • Boca Raton, Florida, Estados Unidos, 33431
        • Reclutamiento
        • Florida Atlantic University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Military veteran with self-reported posttraumatic stress symptoms and/or other mental health conditions
  • Over 18 years of age
  • Applied and approved to adopt a shelter dog for training through the Humane Society of Broward County in Fort Lauderdale, Florida
  • English speaker (written and spoken)
  • Home internet access via tablet, computer or smartphone.

Exclusion Criteria:

  • Fear of dogs
  • Allergies to pet dander
  • Uncorrected hearing or visual impairment.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Study Intervention

Within-subjects design

Eight, one-hour professional dog training sessions over 8-10 weeks

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in self-reported posttraumatic stress disorder (PTSD) symptoms from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of PTSD symptoms with scores ranging from 0 to 80.

From enrollment to 4 weeks post-intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in depression symptom severity from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms with scores ranging from 0 to 27.

From enrollment to 4 weeks post-intervention
Change in anxiety symptom severity from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Generalized Anxiety Disorder-7 (GAD-7) is a is a 7-item self-report measure of anxiety symptoms with scores ranging from 0 to 21.

From enrollment to 4 weeks post-intervention
Change in perceived stress severity from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure of perceived stress symptoms with scores ranging from 0 to 40.

From enrollment to 4 weeks post-intervention
Change in sleep disturbance from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Patient-Reported Outcomes Measurement Information System Sleep 8b (PROMIS Sleep 8b) is an 8-item self-report measure of sleep quality over the past 7 days with raw scores ranging from 8 to 40 and standardized T scores ranging from 28.9 to 76.5.

From enrollment to 4 weeks post-intervention
Change in loneliness from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Revised UCLA Loneliness Scale is a 20-item self-report measure of loneliness with scores ranging from 20 to 80.

From enrollment to 4 weeks post-intervention
Change in alcohol use from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Alcohol Use Disorder Identification Test (AUDIT) is a 10-item self-report measure of alcohol use with scores ranging from 0 to 40.

From enrollment to 4 weeks post-intervention
Change in cannabis use from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Cannabis Use Disorder Identification Test (CUDIT) is an 8-item self-report measure of cannabis use with scores ranging from 0 to 32.

From enrollment to 4 weeks post-intervention
Change in salivary oxytocin levels from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Oxytocin is a neurotransmitter that plays a role in determining social behavior. Salivary oxytocin levels range from 6.4-1000 pg/mL.

From enrollment to 4 weeks post-intervention
Change in Interleukin-1 beta (IL-1β) from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

IL-1β is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-1β is measured via capillary blood obtained via fingerstick.

From enrollment to 4 weeks post-intervention
Change in Interleukin-6 (IL-6) from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

IL-6 is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-6 is measured via capillary blood obtained via fingerstick.

From enrollment to 4 weeks post-intervention
Change in tumor necrosis factor-alpha (TNF-alpha) from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

TNF-alpha is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. TNF-alpha is measured via capillary blood obtained via fingerstick.

From enrollment to 4 weeks post-intervention

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in alcohol demand for participants who answer "yes" to alcohol consumption in the AUDIT measure from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Alcohol Purchase Task is a tool to measure alcohol demand by asking individuals how many drinks they would consume at prices ranging from free to high, using behavioral economic indices for scoring.

From enrollment to 4 weeks post-intervention
Change in cannabis demand for participants who answer "yes" to cannabis use from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention

Cannabis Purchase Task is a tool to measure cannabis demand by assessing how much an individual purchases at increasing prices.

From enrollment to 4 weeks post-intervention
Change in Magnetic Resonance Imaging (MRI) biomarkers from baseline to 4 weeks post-intervention
Periodo de tiempo: Pre-intervention and 4 weeks post-intervention

Optional participation in an MRI to detect changes in the structure and resting-state function of specific brain regions (anterior cingulate, amygdala, hippocampus, and insula)

Pre-intervention and 4 weeks post-intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Beth A Pratt, PhD, Florida Atlantic University
  • Investigador principal: Cheryl A Krause-Parello, PhD, Florida Atlantic University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

9 de febrero de 2026

Finalización primaria (Estimado)

1 de diciembre de 2030

Finalización del estudio (Estimado)

1 de diciembre de 2030

Fechas de registro del estudio

Enviado por primera vez

14 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

14 de abril de 2026

Publicado por primera vez (Actual)

21 de abril de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

6 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • IRB2310227

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .